Archives for March 21, 2024

← 2024

AstraZeneca funding: ‘British companies investing in the UK should not be headline news’

21-Mar-2024

By Isabel Cameron

AstraZeneca recently announced its £650 million investment in the UK, held up by Chancellor Jeremy Hunt as a ‘vote of confidence’ in the country’s life sciences sector.

Pfizer's Braftovi to command 42% share of BRAF inhibitors melanoma market by 2028

21-Mar-2024

By Isabel Cameron

Since Roche's Zelboraf (vemurafenib)gained FDA approval in 2011, significant strides have been made in BRAF-targeted cancer therapies, underscoring the significance of combating BRAF mutations in melanoma.